WALTHAM, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--Life Edit ® Therapeutics Inc., an ElevateBio ® company focused on next-generation gene editing technologies and therapeutics, today announced the ...
Life Edit to receive upfront cash payment, research, and preclinical funding, and is eligible to receive milestone payments with tiered royalties on global net product sales CAMBRIDGE, MA and DURHAM, ...
Life Edit Therapeutics Inc., an Elevatebio LLC company, has presented the first preclinical data from the its Huntington’s disease program.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Life Edit Therapeutics Inc, a next generation gene-editing company, today announced that it has received an award from the Cystic Fibrosis Foundation to ...
ElevateBio has enjoyed a close look at Life Edit Therapeutics over the past 11 months, with overlaps in the management team and involvement in its portfolio of cell and gene therapy companies giving ...
One of Moderna's New Year's resolutions appears to have been to expand its genomics output. The latest move in this area sees the mRNA company pen a partnership with ElevateBio’s Life Edit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results